Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - theophylline, quantity: 20.63 mg/ml; ethylenediamine, quantity: 5.477 mg/ml; ethylenediamine - injection, solution - excipient ingredients: water for injections - aminophylline injection bp is indicated for the treatment of reversible bronchospasm associated with chronic bronchitis, emphysema, bronchial asthma and chronic obstructive pulmonary disease. it may also be used for paroxysmal dyspnoea associated with left heart failure.

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc. - aminophylline dihydrate (unii: c229n9dx94) (theophylline anhydrous - unii:0i55128jyk) - aminophylline dihydrate 25 mg in 1 ml - intravenous theophylline is indicated as an adjunct to inhaled beta-2 selective agonists and systemically administered corticosteroids for the treatment of acute exacerbations of the symptoms and reversible airflow obstruction associated with asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. aminophylline is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product including ethylenediamine.

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - aminophylline dihydrate (unii: c229n9dx94) (theophylline anhydrous - unii:0i55128jyk) - aminophylline dihydrate 25 mg in 1 ml - intravenous theophylline is indicated as an adjunct to inhaled beta-2 selective agonists and systemically administered corticosteroids for the treatment of acute exacerbations of the symptoms and reversible airflow obstruction associated with asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. aminophylline is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product including ethylenediamine.

United States - English - NLM (National Library of Medicine)

hospira, inc. - aminophylline dihydrate (unii: c229n9dx94) (theophylline anhydrous - unii:0i55128jyk) - aminophylline dihydrate 25 mg in 1 ml - intravenous theophylline is indicated as an adjunct to inhaled beta-2 selective agonists and systemically administered corticosteroids for the treatment of acute exacerbations of the symptoms and reversible airflow obstruction associated with asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. aminophylline is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product including ethylenediamine.

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - aminophylline dihydrate (unii: c229n9dx94) (theophylline anhydrous - unii:0i55128jyk) - aminophylline dihydrate 25 mg in 1 ml - intravenous theophylline is indicated as an adjunct to inhaled beta-2 selective agonists and systemically administered corticosteroids for the treatment of acute exacerbations of the symptoms and reversible airflow obstruction associated with asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. aminophylline is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product including ethylenediamine.

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875-00100 nairobi - aminophylline - injection - aminophylline 25mg per ml - aminophylline

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - aminophylline - solution for injection - aminophylline 250 mg / 10 ml - aminophylline - aminophylline - for symptomatic relief or prevention of bronchial asthma and for treatment of reversible bronchospasm associated with chronic bronchitis and emphysema.

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi, kenya - aminophylline - injection - aminophylline 25mg/1ml - other systemic drugs for obstructive airway

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - theophylline hydrate 20.63 mg/ml (as 25mg/ml of aminophylline) - solution for injection - 250 mg/10ml - active: theophylline hydrate 20.63 mg/ml (as 25mg/ml of aminophylline) excipient: edamine as 25mg/ml of aminophylline + extra q.s. to adjust ph (limit nmt 295 mg / g of theophylline) water for injection - dbl™aminophylline injection is indicated for the treatment of reversible bronchospasm associated with chronic bronchitis, emphysema, bronchial asthma and chronic obstructive pulmonary disease. it may also be used for paroxysmal dyspnoea associated with left heart failure

Malta - English - Medicines Authority

mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - aminophylline hydrate - solution for injection - aminophylline hydrate 25 mg/ml - drugs for obstructive airway diseases